arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

DAVITA INC.

DVA
$183.14 ▼ -0.55 (-0.30%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
75 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Bearish
auto_awesome

Analytical Summary

DAVITA INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $11.9B
Dividend Yield
Revenue Growth 5.2%
Op. Margin 16.3%
ROIC -59.7%
FCF / Share $4.94
Trailing P/E 44.7x
Price / Book
FCF Yield 2.7%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.55B
↑ +5.2%
Net Income Profit after all expenses
$265.40M
↑ +33.1%
Operating Margin Operating profit as % of sales
16.3%
↑ +15.5% 67th
FCF / Share Free cash flow per share
$4.94
↑ +52.3%
Long-Term Debt Long-term obligations
$8.50B
↑ +1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
60
Returns
7
Financial Health
69
Cash Quality
83

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 75 quarters